Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-07-056408
Filing Date
2007-09-07
Accepted
2007-09-07 11:52:32
Documents
1
Period of Report
2007-09-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 OF J.J. FINKELSTEIN (SEPTEMBER 6, 2007) rrd171939.html 4  
1 FORM 4 OF J.J. FINKELSTEIN (SEPTEMBER 6, 2007) rrd171939.xml 4 9138
  Complete submission text file 0001181431-07-056408.txt   11120
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address ALPHA 1 BIOMEDICALS INC 3 BETHESDA METRO CENTER BETHSEDA MD 20814 3019611992
FINKELSTEIN J J (Reporting) CIK: 0001125610 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 071104757